Helicobacter pylori (H. pylori) is one of the most common bacterial infections in the world, estimated to affect over 50% of the global population. Despite its prevalence, many people carry H. pylori without knowing it — and the infection can silently contribute to serious digestive and systemic health issues.
What Is H. pylori?
H. pylori is a spiral-shaped bacterium that colonizes the stomach lining. It has evolved sophisticated mechanisms to survive in the highly acidic stomach environment, including the production of urease enzyme which neutralizes stomach acid in its immediate vicinity. This allows it to burrow into the mucous lining and establish a chronic infection.
Symptoms of H. pylori Infection
Many H. pylori infections are asymptomatic. When symptoms do occur, they may include chronic upper abdominal pain or burning, bloating and excessive gas, nausea, loss of appetite, unexplained weight loss, acid reflux or heartburn, iron deficiency anemia, and fatigue. In more severe cases, H. pylori can lead to gastric and duodenal ulcers and is classified as a Group 1 carcinogen by the WHO due to its association with gastric cancer.
Why Virulence Factors Matter
Not all H. pylori strains are equally harmful. The GI-MAP™ test uniquely detects 8 virulence factors that indicate the aggressiveness and pathogenic potential of an H. pylori infection:
cagA (cytotoxin-associated gene A): Associated with increased risk of gastric cancer, peptic ulcers, and more severe inflammation. vacA (vacuolating cytotoxin A): Causes damage to epithelial cells and modulates immune response. babA (blood group antigen-binding adhesin): Facilitates adherence to gastric epithelium. dupA (duodenal ulcer promoting gene): Associated with duodenal ulcer development. oipA (outer inflammatory protein): Enhances mucosal inflammation. iceA (induced by contact with epithelium): Activated during contact with gastric cells. virB and virD: Part of the type IV secretion system used to inject toxins into host cells.
Potential Complications of Untreated Infection
Most people who carry H. pylori never develop serious problems, but in a subset of cases chronic infection can lead to meaningful complications. The best understood is peptic ulcer disease — sores in the lining of the stomach or the first part of the small intestine — for which H. pylori, along with NSAID use, is one of the most common causes. Chronic inflammation of the stomach lining (gastritis) is also strongly linked to the organism. Over many years, persistent infection modestly raises the risk of gastric cancer, which is why H. pylori is classified by the World Health Organization as a Group 1 carcinogen, and it is associated with a rare lymphoma of the stomach known as MALT lymphoma. These outcomes are the exception rather than the rule, but they are the reason confirmed infections are generally treated rather than left alone.
When to See a Doctor
Certain symptoms warrant prompt medical attention regardless of testing. Black or tarry stools, vomiting blood or material that looks like coffee grounds, severe or persistent abdominal pain, difficulty swallowing, and unexplained weight loss can be signs of an ulcer or other serious problem and should be evaluated by a physician without delay. A comprehensive stool panel is a tool for understanding chronic patterns, not an emergency assessment.
How H. pylori Is Diagnosed
There are several established ways to test for H. pylori, and they answer slightly different questions. The most common clinical options are the urea breath test, the stool antigen test, and biopsy-based testing taken during an endoscopy. Blood antibody tests also exist, but because antibodies can persist after an infection has cleared, a positive blood test does not always mean a current, active infection. For confirming that an infection is present or that treatment has worked, breath and stool tests are generally preferred.
Molecular stool testing adds another layer. Rather than looking for a single antigen, the qPCR approach used by the GI-MAP™ detects H. pylori DNA directly and reports an approximate quantity, and it screens for the virulence-factor genes described below in the same run. This is why some practitioners use it as part of a broader gut workup, particularly when symptoms are chronic and other testing has been inconclusive. Whichever method is used, accurate testing depends on timing relative to medications: proton pump inhibitors (PPIs), bismuth, and recent antibiotics can all suppress the organism and produce false-negative results, so your practitioner may ask you to pause certain medications before collection.
Why Virulence Factor Testing Matters Clinically
The practical value of virulence-factor testing is that it helps a practitioner weigh risk. A strain carrying cagA and certain vacA variants is, on average, associated in the research literature with more intense inflammation and a higher likelihood of ulcers and gastric complications than a strain without those genes. That information does not by itself dictate a treatment plan, but it can inform a conversation about how closely to monitor an infection and how to prioritize it among other findings. Decisions about whether and how to treat always belong with a qualified clinician.
How H. pylori Is Treated
Treatment of H. pylori is the domain of a physician and typically involves a combination of antibiotics plus an acid-suppressing medication, taken together for a defined course. Major gastroenterology guidelines, including those from the American College of Gastroenterology, commonly describe bismuth quadruple therapy — a proton pump inhibitor combined with bismuth and two antibiotics for roughly 10 to 14 days — as a first-line option when local antibiotic resistance patterns are unknown. Antibiotic resistance is a growing challenge, which is one reason regimens have shifted toward longer courses and multiple agents.
Guidelines also emphasize confirming eradication after treatment, generally with a urea breath test or stool antigen test performed at least four weeks after finishing antibiotics and after pausing acid-suppressing medication for one to two weeks. Self-treating H. pylori with supplements alone is not a substitute for this medically supervised process. Some people work with their practitioner on supportive measures alongside or after standard treatment, but the eradication itself is a clinical decision.
GI-MAP™ Detection Advantage
The GI-MAP™'s qPCR technology can detect H. pylori at the DNA level, even when the organism is present in very low quantities or is not actively culturable. Combined with virulence factor testing, this gives practitioners additional information to guide their assessment. A cagA-positive, vacA-positive strain may prompt a different conversation than a strain without these factors. The GI-MAP™ also places any H. pylori finding in the context of the rest of the gut — inflammation markers, beneficial bacteria, opportunistic overgrowths, and parasites — which can matter when symptoms have more than one driver. You can read more about the full panel in our overview of what the GI-MAP™ test is and how it works, or preview the layout on our sample report page.
If your primary concern is Helicobacter pylori specifically, there is a focused H. pylori profile that concentrates on the organism and its virulence factors, while the comprehensive GI-MAP™ Standard covers H. pylori alongside the rest of the microbiome. If you suspect H. pylori, you can order a test online — no referral required — and review the results with a practitioner who can guide next steps.
Frequently Asked Questions
Is H. pylori contagious?
H. pylori is thought to spread from person to person through contact with saliva, vomit, or stool, and through contaminated food or water. Infections are often acquired in childhood and can persist for life if untreated.
Can H. pylori go away on its own?
Established H. pylori infections rarely clear without treatment. Because untreated chronic infection can contribute to ulcers and raise the risk of gastric cancer over time, it is generally addressed rather than ignored once confirmed.
Should everyone with H. pylori be treated?
Many guidelines support treating H. pylori whenever it is found, but the right approach for an individual — including timing and regimen — is a clinical judgment that depends on symptoms, history, and local antibiotic resistance. Discuss your results with a physician.
Sources
This article summarizes published guidance and peer-reviewed literature on H. pylori. It is educational and not a substitute for medical advice; testing and treatment decisions should be made with a qualified clinician.